B

Beijing Airdoc Technology Co Ltd
HKEX:2251

Watchlist Manager
Beijing Airdoc Technology Co Ltd
HKEX:2251
Watchlist
Price: 12.1 HKD 1.17%
Market Cap: 1.3B HKD
Have any thoughts about
Beijing Airdoc Technology Co Ltd?
Write Note

Beijing Airdoc Technology Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Beijing Airdoc Technology Co Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Beijing Airdoc Technology Co Ltd
HKEX:2251
Cash Equivalents
ÂĄ891.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Y
Yidu Tech Inc
HKEX:2158
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medlive Technology Co Ltd
HKEX:2192
Cash Equivalents
ÂĄ4.4B
CAGR 3-Years
209%
CAGR 5-Years
205%
CAGR 10-Years
N/A
Guiyang Longmaster Information & Technology Co Ltd
SZSE:300288
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B-SOFT Co Ltd
SZSE:300451
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Winning Health Technology Group Co Ltd
SZSE:300253
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Beijing Airdoc Technology Co Ltd
Glance View

Market Cap
1.3B HKD
Industry
Health Care

Beijing Airdoc Technology Co. Ltd. engages in the provision of AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions. The company is headquartered in Beijing, Beijing and currently employs 369 full-time employees. The company went IPO on 2021-11-05. The firm's main product is Airdoc-AIFUNDUS 1.0. The firm's product can be used in the diagnosis of glaucoma, cataract, ICVD and ASCVD, diabetic retinopathy of pregnancy, hypertensive retinopathy of pregnancy and other diseases. In addition, the Company has developed a deep pipeline of other Software-as-a-medical devices (SaMDs) and health risk assessment solutions to address various healthcare needs for the whole population, including hospitals, community clinics, health checkup centers, insurance companies, optometry centers and pharmacies.

Intrinsic Value
19.61 HKD
Undervaluation 38%
Intrinsic Value
Price
B

See Also

What is Beijing Airdoc Technology Co Ltd's Cash Equivalents?
Cash Equivalents
891.5m CNY

Based on the financial report for Dec 31, 2023, Beijing Airdoc Technology Co Ltd's Cash Equivalents amounts to 891.5m CNY.

What is Beijing Airdoc Technology Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 1Y
-30%

Over the last year, the Cash Equivalents growth was -30%.

Back to Top